UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Tramadol Prescription over a 4-Year Period in the USA

Current pain and headache reports, 2019-10, Vol.23 (10), Article 76

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study

Journal of the American Academy of Dermatology, 2024-03, Vol.90 (3), p.521-529

2024

Link zum Volltext

Verfügbarkeit prüfen

Patterns in opioid prescription in the United States by region and prescribers over a 4-year period

Journal of opioid management, 2019-11, Vol.15 (6), p.499

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine

Current drug safety, 2015-01, Vol.10 (2), p.152

2015

Link zum Volltext

Verfügbarkeit prüfen

34630 The mental health and psychosocial burden among patients living with vitiligo in the United States: Findings from the VALIANT study

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB119-AB119

2022

Link zum Volltext

Verfügbarkeit prüfen

Medication Guide Reading Behaviors and Attitudes Among Subjects With Migraine, Asthma, or COPD

Therapeutic innovation & regulatory science, 2015-05, Vol.49 (3), p.377-386

2015

Link zum Volltext

Verfügbarkeit prüfen

Tramadol Prescription over a 4-Year Period in the USA

Current pain and headache reports, 2019-08, Vol.23 (10)

2019

Link zum Volltext

Verfügbarkeit prüfen

16983 Quality of life in patients with vitiligo: Results from a global patient survey

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB76-AB76

2020

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial Effects of Vitiligo: A Systematic Literature Review

American journal of clinical dermatology, 2021-11, Vol.22 (6), p.757-774

2021

Link zum Volltext

Verfügbarkeit prüfen

34631 Do patients with vitiligo and health care professionals treating them recognize the burden in living with the disease in the United States? Findings from the VALIANT study

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB159-AB159

2022

Link zum Volltext

Verfügbarkeit prüfen

34612 Exploring the natural history of vitiligo in the United States: Findings from the VALIANT study

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB167-AB167

2022

Link zum Volltext

Verfügbarkeit prüfen

Tramadol Prescription over a 4-Year Period in the USA

Current pain and headache reports, 2019-08, Vol.23 (10), p.76-7

2019

Link zum Volltext

Verfügbarkeit prüfen

Exploring the diagnostic journey and life impact of patients with cholangiocarcinoma (CCA): Results from a large patient survey in the United States

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.277-277

2021

Link zum Volltext

Verfügbarkeit prüfen

17755 Global survey investigating the prevalence of vitiligo and vitiligo signs among adults in Europe, Japan, and the United States

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB198-AB198

2020

Link zum Volltext

Verfügbarkeit prüfen

43959 Vitiligo Noticeability Scale Score Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB104-AB104

2023

Link zum Volltext

Verfügbarkeit prüfen

Rates of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) from Center for International Blood and Marrow Transplant Research (CIBMTR) data on US subjects (SUBJ) with lymphoma following chimeric antigen receptor T cell therapy (CAR-T)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7528-7528

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic journey and life impact of cholangiocarcinoma: results from surveys of patient and caregiver experiences

Future oncology (London, England), 2024-05, Vol.20 (15), p.997

2024

Link zum Volltext

Verfügbarkeit prüfen

Progression-free survival in patients with cholangiocarcinoma with FGFR2 fusions or rearrangements: An exploration of response to systemic therapy

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.588-588

2020

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal evaluation of quality of life (QoL) in patients (Pts) with FGFR2-driven cholangiocarcinoma (CCA) treated with pemigatinib

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.276-276

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.303-303

2021

Link zum Volltext

Verfügbarkeit prüfen

Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study

British journal of dermatology (1951), 2023-10, Vol.189 (5), p.569-577

2023

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality-of-life in patients with cholangiocarcinoma: Results of a systematic literature review

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15623-e15623

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Headache, 2021-04, Vol.61 (4), p.662-672

2021

Link zum Volltext

Verfügbarkeit prüfen

Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study

Headache, 2020-11, Vol.60 (10), p.2444-2453

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma

Targeted oncology, 2022-09, Vol.17 (5), p.517-527

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(9)
Clinical Neurology
(4)
Female
(4)
Male
(4)
Neurosciences & Neurology
(4)
Adult
(3)
Analgesics, Opioid - Therapeutic Use
(3)
Comorbidity
(3)
Dermatology
(3)
Drug Prescriptions - Statistics & Numerical Data
(3)
Medicine
(3)
Medicine & Public Health
(3)
Middle Aged
(3)
Patients
(3)
Pharmacology & Pharmacy
(3)
Pharmacotherapy
(3)
Prevalence
(3)
Quality Of Life
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tramadol Prescription over a 4-Year Period in the USA

Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study

Patterns in opioid prescription in the United States by region and prescribers over a 4-year period

Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine

34630 The mental health and psychosocial burden among patients living with vitiligo in the United States: Findings from the VALIANT study

Medication Guide Reading Behaviors and Attitudes Among Subjects With Migraine, Asthma, or COPD

Tramadol Prescription over a 4-Year Period in the USA

16983 Quality of life in patients with vitiligo: Results from a global patient survey

Psychosocial Effects of Vitiligo: A Systematic Literature Review

34631 Do patients with vitiligo and health care professionals treating them recognize the burden in living with the disease in the United States? Findings from the VALIANT study

34612 Exploring the natural history of vitiligo in the United States: Findings from the VALIANT study

Tramadol Prescription over a 4-Year Period in the USA

Exploring the diagnostic journey and life impact of patients with cholangiocarcinoma (CCA): Results from a large patient survey in the United States

17755 Global survey investigating the prevalence of vitiligo and vitiligo signs among adults in Europe, Japan, and the United States

43959 Vitiligo Noticeability Scale Score Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies

Rates of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) from Center for International Blood and Marrow Transplant Research (CIBMTR) data on US subjects (SUBJ) with lymphoma following chimeric antigen receptor T cell therapy (CAR-T)

Diagnostic journey and life impact of cholangiocarcinoma: results from surveys of patient and caregiver experiences

Progression-free survival in patients with cholangiocarcinoma with FGFR2 fusions or rearrangements: An exploration of response to systemic therapy

Longitudinal evaluation of quality of life (QoL) in patients (Pts) with FGFR2-driven cholangiocarcinoma (CCA) treated with pemigatinib

Effect of FGFR2 alterations on survival in patients receiving systemic chemotherapy for intrahepatic cholangiocarcinoma

Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study

Health-related quality-of-life in patients with cholangiocarcinoma: Results of a systematic literature review

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM Study

Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma

Suchergebnisse filtern